Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

BACKGROUND: Podocalyxin-like 1 (PODXL) is a cell-adhesion glycoprotein and stem cell marker that has been associated with an aggressive tumour phenotype and adverse outcome in several cancer types. We recently demonstrated that overexpression of PODXL is an independent factor of poor prognosis in co...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, Anna, Fridberg, Marie, Gaber, Alexander, Nodin, Björn, Levéen, Per, Jönsson, Göran, Uhlén, Mathias, Birgisson, Helgi, Jirström, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492217/
https://www.ncbi.nlm.nih.gov/pubmed/22769594
http://dx.doi.org/10.1186/1471-2407-12-282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492217/
https://www.ncbi.nlm.nih.gov/pubmed/22769594
http://dx.doi.org/10.1186/1471-2407-12-282

Ejemplares similares